173 related articles for article (PubMed ID: 33833824)
1. Upregulated Tripartite Motif 47 Could Facilitate Glioma Cell Proliferation and Metastasis as a Tumorigenesis Promoter.
Ji B; Liu L; Guo Y; Ming F; Jiang J; Li F; Zhao G; Wen J; Li N
Comput Math Methods Med; 2021; 2021():5594973. PubMed ID: 33833824
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of TRIM47 inhibits glioma cell proliferation, migration and invasion through the inactivation of Wnt/β-catenin pathway.
Chen L; Li M; Li Q; Xu M; Zhong W
Mol Cell Probes; 2020 Oct; 53():101623. PubMed ID: 32603762
[TBL] [Abstract][Full Text] [Related]
3. TRIM47 promotes glioma angiogenesis by suppressing Smad4.
Wang Z; Li Z; Han C; Cheng Y; Wang K
In Vitro Cell Dev Biol Anim; 2022 Oct; 58(9):771-779. PubMed ID: 36203070
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of TRIM47 inhibits breast cancer tumorigenesis and progression through the inactivation of PI3K/Akt pathway.
Wang Y; Liu C; Xie Z; Lu H
Chem Biol Interact; 2020 Feb; 317():108960. PubMed ID: 31981573
[TBL] [Abstract][Full Text] [Related]
5. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
Han Y; Tian H; Chen P; Lin Q
Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
[TBL] [Abstract][Full Text] [Related]
6. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.
Liang Q; Tang C; Tang M; Zhang Q; Gao Y; Ge Z
J Exp Clin Cancer Res; 2019 Apr; 38(1):159. PubMed ID: 30979374
[TBL] [Abstract][Full Text] [Related]
7. Increased Expression of Tripartite Motif (TRIM) 47 Is a Negative Prognostic Predictor in Human Prostate Cancer.
Fujimura T; Inoue S; Urano T; Takayama K; Yamada Y; Ikeda K; Obinata D; Ashikari D; Takahashi S; Homma Y
Clin Genitourin Cancer; 2016 Aug; 14(4):298-303. PubMed ID: 26873435
[TBL] [Abstract][Full Text] [Related]
8. Trim47 overexpression correlates with poor prognosis in gastric cancer.
Xia Y; Wei Z; Huang W; Wei X; He Y
Neoplasma; 2021 Mar; 68(2):307-316. PubMed ID: 33350849
[TBL] [Abstract][Full Text] [Related]
9. TRIM47 promotes ovarian cancer cell proliferation, migration, and invasion by activating STAT3 signaling.
Wang X; Fu Y; Xing Y
Clinics (Sao Paulo); 2022; 77():100122. PubMed ID: 36288633
[TBL] [Abstract][Full Text] [Related]
10. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
[TBL] [Abstract][Full Text] [Related]
11. Adaptor Protein Complex 1 Sigma 3 Is Highly Expressed in Glioma and Could Enhance Its Progression.
Ye T; Cheng Y; Li C
Comput Math Methods Med; 2021; 2021():5086236. PubMed ID: 34367317
[TBL] [Abstract][Full Text] [Related]
12. Loss of 5'-Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, it is Not Associated with Higher Tumor Aggressiveness.
Menezes WP; Silva VAO; Gomes INF; Rosa MN; Spina MLC; Carloni AC; Alves ALV; Melendez M; Almeida GC; Silva LSD; Clara C; da Cunha IW; Hajj GNM; Jones C; Bidinotto LT; Reis RM
Cells; 2020 Feb; 9(2):. PubMed ID: 32093414
[TBL] [Abstract][Full Text] [Related]
13. CRNDE/ETS1/GPR17 Facilitates the Proliferation, Migration, and Invasion of Glioma.
Hu Y; Luo H; Zhu X; Guo H
Comput Math Methods Med; 2021; 2021():7566365. PubMed ID: 34853603
[TBL] [Abstract][Full Text] [Related]
14. A Novel Tumor-Suppressor, CDH18, Inhibits Glioma Cell Invasiveness Via UQCRC2 and Correlates with the Prognosis of Glioma Patients.
Bai YH; Zhan YB; Yu B; Wang WW; Wang L; Zhou JQ; Chen RK; Zhang FJ; Zhao XW; Duan WC; Wang YM; Liu J; Bao JJ; Zhang ZY; Liu XZ
Cell Physiol Biochem; 2018; 48(4):1755-1770. PubMed ID: 30078018
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of TREM2 enhances glioma cell proliferation and invasion: a therapeutic target in human glioma.
Wang XQ; Tao BB; Li B; Wang XH; Zhang WC; Wan L; Hua XM; Li ST
Oncotarget; 2016 Jan; 7(3):2354-66. PubMed ID: 26506595
[TBL] [Abstract][Full Text] [Related]
16. miR-193a-3p Promotes the Invasion, Migration, and Mesenchymal Transition in Glioma through Regulating BTRC.
Zhou DD; Li HL; Liu W; Zhang LP; Zheng Q; Bai J; Hu YQ; Yin CG; Lv SJ; Zhang BG
Biomed Res Int; 2021; 2021():8928509. PubMed ID: 33628829
[TBL] [Abstract][Full Text] [Related]
17. Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis.
Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
J Mol Neurosci; 2020 Oct; 70(10):1521-1532. PubMed ID: 32642801
[TBL] [Abstract][Full Text] [Related]
18. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
19. miR-1908 as a novel prognosis marker of glioma via promoting malignant phenotype and modulating SPRY4/RAF1 axis.
Chai Z; Fan H; Li Y; Song L; Jin X; Yu J; Li Y; Ma C; Zhou R
Oncol Rep; 2017 Nov; 38(5):2717-2726. PubMed ID: 29048686
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis regarding the correlation between GAS2 family genes and human glioma prognosis.
Zhao C; Zhang N; Cui X; Zhang X; Ren Y; Su C; He J; Zhang W; Sun X; Yang J; Gao X
Cancer Med; 2021 Apr; 10(8):2826-2839. PubMed ID: 33713047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
